迈瑞医疗
(300760)
| 流通市值：1718.37亿 | | | 总市值：1719.85亿 |
| 流通股本：12.11亿 | | | 总股本：12.12亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 8,352,015,912 | 33,282,159,404 | 25,833,906,543 | 16,743,003,854 |
| 营业收入 | 8,352,015,912 | 33,282,159,404 | 25,833,906,543 | 16,743,003,854 |
| 二、营业总成本 | 5,905,265,678 | 23,608,910,747 | 17,055,866,071 | 10,992,966,764 |
| 营业成本 | 3,184,616,660 | 13,207,838,172 | 9,829,018,551 | 6,418,018,807 |
| 税金及附加 | 94,353,056 | 389,477,342 | 302,964,242 | 197,869,656 |
| 销售费用 | 1,239,689,610 | 5,145,135,431 | 3,735,210,386 | 2,423,934,190 |
| 管理费用 | 343,826,411 | 1,550,675,756 | 1,046,880,948 | 682,196,711 |
| 研发费用 | 801,738,588 | 3,578,692,207 | 2,434,870,090 | 1,606,602,668 |
| 财务费用 | 241,041,353 | -262,908,161 | -293,078,146 | -335,655,268 |
| 其中:利息费用 | 6,070,916 | 24,024,138 | 16,751,412 | 10,300,387 |
| 其中:利息收入 | 114,163,421 | 479,906,226 | 358,085,286 | 236,093,967 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,007,831 | 485,746 | 669,858 | 250,473 |
| 加:投资收益 | 10,229,985 | 114,953,316 | 111,310,332 | 100,922,057 |
| 资产处置收益 | -7,089,989 | 10,715,933 | 9,892,876 | 736,574 |
| 资产减值损失(新) | -20,814,987 | -335,842,079 | -203,062,364 | -108,538,077 |
| 信用减值损失(新) | -9,522,134 | -196,027,800 | -156,211,934 | -120,961,914 |
| 其他收益 | 103,850,398 | 527,360,218 | 406,772,773 | 299,959,868 |
| 四、营业利润 | 2,524,411,338 | 9,794,893,991 | 8,947,412,013 | 5,922,406,071 |
| 加:营业外收入 | 24,549,320 | 34,428,279 | 18,911,609 | 12,607,181 |
| 减:营业外支出 | 7,612,978 | 155,356,531 | 64,711,790 | 18,107,171 |
| 五、利润总额 | 2,541,347,680 | 9,673,965,739 | 8,901,611,832 | 5,916,906,081 |
| 减:所得税费用 | 114,809,554 | 1,222,494,334 | 1,087,718,256 | 684,213,893 |
| 六、净利润 | 2,426,538,126 | 8,451,471,405 | 7,813,893,576 | 5,232,692,188 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 2,426,538,126 | 8,451,471,405 | 7,813,893,576 | 5,232,692,188 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 2,329,658,005 | 8,135,775,409 | 7,570,044,518 | 5,068,767,098 |
| 少数股东损益 | 96,880,121 | 315,695,996 | 243,849,058 | 163,925,090 |
| 扣除非经常损益后的净利润 | 2,296,470,040 | 8,068,550,808 | 7,462,681,541 | 4,949,323,103 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.92 | 6.71 | 6.25 | 4.18 |
| (二)稀释每股收益 | 1.92 | 6.71 | 6.25 | 4.18 |
| 八、其他综合收益 | -243,472,238 | 278,427,564 | 399,264,979 | 479,585,047 |
| 归属于母公司股东的其他综合收益 | -236,962,743 | 254,979,713 | 368,192,867 | 449,177,546 |
| 九、综合收益总额 | 2,183,065,888 | 8,729,898,969 | 8,213,158,555 | 5,712,277,235 |
| 归属于母公司股东的综合收益总额 | 2,092,695,262 | 8,390,755,122 | 7,938,237,385 | 5,517,944,644 |
| 归属于少数股东的综合收益总额 | 90,370,626 | 339,143,847 | 274,921,170 | 194,332,591 |
| 公告日期 | 2026-04-29 | 2026-03-31 | 2025-10-30 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |